{"created":"2023-05-15T14:46:45.839042+00:00","id":64158,"links":{},"metadata":{"_buckets":{"deposit":"afdd78a2-4960-4a3a-b5f0-f16211ba15f6"},"_deposit":{"created_by":1,"id":"64158","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"64158"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00064158","sets":["10:29"]},"author_link":["632820","632823","632826","632817","632824","632819","632822","632821","632818","632825"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2009-04-14","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The purpose of this research is to investigate combination of molecular targeting drugs and carbon ion beam radiotherapy for esophageal squamous cell cancer. We used TE-2 and T.Tn cells and Balb/c nu/nu mice for in vitro and in vivo experiment. As the molecular targeting drugs, we used histone deacetylase inhibitor(Compound A, or B) and FIR gene transfer by adenovirus vectors. In the combination of Compound A and Carbon ion radiotherapy or X-ray radiotherapy, growth suppression is potentiated as compared to that treated with either alone for in vitro and in vivo experiment.","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"平成20年度HIMAC共同利用研究成果発表会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"加野, 将之"}],"nameIdentifiers":[{"nameIdentifier":"632817","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"山田, 滋"}],"nameIdentifiers":[{"nameIdentifier":"632818","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"松下, 一之"}],"nameIdentifiers":[{"nameIdentifier":"632819","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"辻井, 博彦"}],"nameIdentifiers":[{"nameIdentifier":"632820","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"松原, 久裕"}],"nameIdentifiers":[{"nameIdentifier":"632821","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"加野 将之","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"632822","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"山田 滋","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"632823","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"松下 一之","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"632824","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"辻井 博彦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"632825","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"松原 久裕","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"632826","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"食道扁平上皮癌に対する重粒子線と分子標的治療薬の併用効果の基礎的検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"食道扁平上皮癌に対する重粒子線と分子標的治療薬の併用効果の基礎的検討"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2010-12-14"},"publish_date":"2010-12-14","publish_status":"0","recid":"64158","relation_version_is_last":true,"title":["食道扁平上皮癌に対する重粒子線と分子標的治療薬の併用効果の基礎的検討"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:14:47.366625+00:00"}